Medication options for obesity have advanced significantly in recent years. In this episode, we cover the key principles of pharmacotherapy, its possibilities and limitations. You will learn why medication is not a miracle cure but can serve as important support for individualized lifestyle changes. We present the core pillars of pharmacotherapy and review different obesity management medication options:
Mysimba (naltrexone/bupropion): An oral combination medication that affects the brain’s reward system and curbs appetite.
Saxenda (liraglutide): An injectable GLP-1 analogue that increases feelings of fullness.
Wegovy (semaglutide): An injectable GLP-1 analogue that regulates appetite and increases satiety.
Mounjaro (tirzepatide): The newest injectable GLP-1/GIP analogue, which affects appetite and blood glucose control.
Qsiva/Qsymia (phentermine/topiramate): A capsule-based combination medication that influences both appetite and metabolism.
Orlistat: Prevents the absorption of fats from food. Also available without a prescription.









